News Sentiment

OBIO sentiment intelligence

Orchestra BioMed Holdings Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 3.99 Week of 10 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

81/100 classification confidence.

Company focus 46

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-4.8% over one week, -2.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Price to earnings forward of Orchestra BioMed Holdings, Inc. – BOATS:OBIO

Market Reaction

Price moving ahead of tone

63/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 81/100 classification
One-week reaction -4.8% Price reacting lower
Trend fit Trend inactive -2.7% over four weeks
Fair value -20.9% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 15
Neutral 33
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 46
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 9
Market source 7
GlobeNewswire 6
TradingView 4
Investing.com 3
TradingKey 3
www.marketscreener.com 2
Investing.com Nigeria 2

Event Lens

What the news is about

Classified themes
Market update 31
Earnings 17
Analyst action 4
Macro sensitivity 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54
TradingKey Direct company coverage

Orchestra Biomed Holdings Inc (OBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Orchestra Biomed Holdings Inc (OBIO) has an earnings forecast score of 8.00, placing it 66th in its industry, with analysts setting an average price target of $12.00. The company's expected revenue for the next quarter is $121.40K, and the majority of analysts recommend a "Buy" r

Tone
Neutral 50/100
Event
Earnings
Published
17 Jun 2026 23:10
Source
TradingKey
TradingKey Direct company coverage

Orchestra Biomed Holdings Inc (OBIO) Financial Health: Profitability & Balance Sheet Analysis

Orchestra Biomed Holdings Inc (OBIO) has a current financial score of 5.60, placing it 196 out of 204 in the Healthcare Equipment & Supplies industry. The company's financial status is stable, but operating efficiency is low, with its latest quarterly revenue decreasing by 87.33%

Tone
Negative 36/100
Event
Earnings
Published
17 Jun 2026 22:10
Source
TradingKey